Manchester United defender Diogo Dalot has backed the health supplement provider with over £841k.
Bioniq offers personalised nutritional supplements driven by blood biomarker data and artificial intelligence. The firm serves customers across seventy countries globally.
Manchester United right-back Diogo Dalot has invested £841k into Bioniq to support the expansion of its data-driven nutritional supplements. Dalot joins existing high-profile backer Cristiano Ronaldo in backing the London-based health firm. The capital follows a Series B round raised by the business last year as it scales its global footprint.
From the founder
"Diogo has an exceptional approach to performance optimization and recovery, constantly seeking the most effective and scientifically backed methods to enhance his physical and cognitive capabilities. His dedication to craft and commitment to maximizing potential makes him a perfect fit for Bioniq. He shares our vision and mission, recognizing that the future of health lies in precision, personalization, and efficacy. His investment is yet another testament to this shift — where science-driven, individualized solutions create meaningful impact in the industry and everyday well-being."
Vadim Fedotov
Founder and CEO at Bioniq
Investor perspective
"When it comes to high-level performance, my biggest focus has always been finding that extra 1% — the key to setting myself apart from the rest. Since discovering Bioniq in 2022, it’s been a game-changer for me. I’ve seen the results for myself. Achieving such progress is only possible with a product that’s truly personalized and tailored specifically to my needs. Now, I’m thrilled to take the next step as an investor. I believe in Bioniq’s mission and see the tremendous potential of this business, especially with the growing global demand for personalized nutrition."
Diogo Dalot
Investor, Diogo Dalot
Investors
Categories
About the company
Bioniq
Bioniq provides personalised nutritional supplements formulated from blood biomarker data.